Clinical Trial

Effect of Collavant® n2 in Healthy Male Adults With Exercise-induced Joint Discomfort.

Study acronym: COLLMOTION
Recruiting
View on ClinicalTrials.gov →
Summary
The present clinical study has been designed to evaluate the effect of Collavant® n2 at a daily dose of 40 mg on joint function and performance in healthy, amateur male runners with exercise-induced knee discomfort.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-14
Trial Details
NCT Number NCT07561203
Lead Sponsor Bioiberica
Collaborators: Universidad Politecnica de Madrid
Conditions Healthy Adult Male
Enrollment 80 participants
Start Date 2026-05-06
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-13